当前位置: 首页 > 详情页

Colony-stimulating factor 1 receptor inhibition blocks macrophage infiltration and endometrial cancer cell proliferation

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Gynecology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu 223300 [2]Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University [3]Department of Basic Research, Institute of Radiotherapy and Oncology, Soochow University,Suzhou, Jiangsu 215004, P.R. China
出处:
ISSN:

关键词: tumor-associated macrophages endometrial cancer colony-stimulating factor 1 colony-stimulating factor 1 receptor

摘要:
Tumor-associated macrophages (TAMs) promote the progression of endometrial cancer (EC), but the mechanism of TAM in EC cell proliferation remains unclear. It was found that colony stimulating factor (CSF)-1 and CSF-1 receptor (CSF-1R) were highly expressed in EC tissues of patients and two EC cell lines (ECC-1 and HEC-1A). Using wound-healing and chemotactic migration assays to evaluate the role of EC cells in the induction of macrophage migration, it was found that the supernatant of EC cells promoted macrophage cell line (U937) migration; however, the migration capacity of U937 weakened when CSF-1R was blocked. Subsequently, inhibition of CSF-1 expression in EC cells also restrained U937 migration. Additionally, blocking CSF-1R by PLX3397 treatment in U937 cells inhibited EC cell proliferation in a co-culture system by inhibiting the expression of proliferation-associated proteins (Janus kinase-1, phosphoinositide 3-kinase, AKT, cyclin kinase 2, 4 and retinoblastoma-associated protein). Together, these results demonstrated that CSF-1 secreted by EC cells promoted macrophage migration; similarly, CSF-1-stimulated macrophages promoted EC cell proliferation. These results suggested that the interaction between CSF-1 and its receptor served an important role in promoting macrophage infiltration and progression of EC.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 医学:研究与实验 4 区 肿瘤学
JCR分区:
出版当年[2017]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL Q4 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY Q2 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Department of Gynecology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu 223300 [2]Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University
通讯作者:
通讯机构: [*1]Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou, Jiangsu 215004, P.R. China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院